A. Types of Reactions
- Adverse Reaction (any of the following)
- Food Hypersensitivity / Allergies
- Immunologically mediated reaction to food or additive
- Mainly glycoproteins (MW 10-60K)
- Cow milk caseins
- Whey
- Chicken egg white
- Peanuts (see below)
- Tree nuts
- Soybeens
- Fish
- Shrimp and other shellfish
- Strawberries
- Food Anaphylaxis - classic hypersensitivity reaction
- Food Intolerance - non-immunologically mediated reaction to food or additive
- Food Toxicity (Poisoning)
- Adverse reaction caused by direct effect of food or additive
- Usually due to toxins in food, often produced by microorganism
- Food Idiosyncrasy
- Nonimmunologically mediated reaction to specific foods or additives by certain groups
- Reaction to monosodium glutamate (MSG; also called Chinese Restaurant Syndrome)
- Anaphylactoid Reaction
- Nonimmune release of chemical mediators
- Common reactions to strawberries, wine, egg whites, tomatoes, citrus
- Pharmacologic Reactions
- Drug-like or pharmacologic effect
- Common reactions to ethanol, caffeine
- Metabolic Food Reaction
- Adverse reaction to food or additive due to specific host reaction
- Lactose Intolerance, Celiac Sprue
B. Classification
- Immunologic
- Immediate Hypersensitivity - IgE mediated
- Mixed IgE / Cell Mediated reactions (subacute and chronic)
- Subacute or Chronic Hypersensitivity - Non-IgE mediated immune mechanisms
- Non-IgE types mediated primarily by T cells
- IgE Dependent
- Urticaria / angioedema
- Immediate gastrointestinal reaction
- Oral allergy syndrome (pollen-related); rhinitis
- Asthma
- Anaphylaxis
- Food associated, exercise induced anaphylaxis
- Subacute or Chronic IgE and/or Cell Mediated
- Atopic dermatitis (infant / child)
- Eosinophilic gastroenteropathies
- Cell Mediated (Delayed Onset)
- Dietary protein enterocolitis (infants)
- Dietary protein proctitis (infants)
- Dietary protein enteropathy (usually due to cow's milk; infants and children)
- Celiac disease and dermatitis herpetiformis
- Extrinsic
- Toxic
- Anaphylactoid
- Pharmacologic
C. Mechanisms
- Food reactions more common in infancy than later
- Many specific food reactions are due to immunologic mechanisms
- Appear to be triggered by gut penetration of intact antigen (as peptide fragments)
- Local allergic reactions in the gut make the mucosa more permeable to larger peptides
- Th2 T helper cell dominance appears to play major role
- Th2 cells produce interleukin (IL) 4, IL5, IL9, IL13 and other Th2 cytokines
- ~35% of adults develop antibodies after milk ingestion (± symptoms)
- Properties of Food Antigens
- Usually proteins or glycoproteins
- MW 18-36K (similar in size to inhalent antigens)
- Adequate cooking destroys most antigens, renders food non-allergenic
- Cross-Reactions
- Plants within same botanical family have potential for cross reactions
- Especially true of legumes, real nuts, citrus fruits
- Marine animals of same family cross react - crustaceans, mollusks, bony fish
- Mammals rarely if ever cross react
- Birch pollen cross-reacts with apple; ragweed pollen cross-reacts with melon
- Latex IgE can cross-react with banana, alvacado, kiwi, chestnut, soybean, peanut
D. Peanut Allergy [2,3,5]
- Increasing prevlance over past several decades for unclear reasons
- >1% of children <5 years
- Food allergies in >7% of children <4 years overall
- >20% of infants with peanut allergies will outgrow their allergy
- Genetic Predispoition
- Concordance rate 64% in identical and 7% in fraternal twins
- Therefore, strong genetic predisposition
- Immunology
- Sensitization to peanut protein may occur in children due to peanut oil on skin
- Peanut protein, not carbohydrate or fat, is immunologic (allergic) target
- Eight peanut allergens have been identified (Ara h1-8)
- Ara h1 and h2 are the major allergens (vicilin and conglutin families of seed storage proteins)
- IgE antibodies specific for peanut protein bind mediate allergy
- IgE-peanut protein complex then binds primarily mast cells and basophils
- This immune complex binding leads to release of inflammatory mediators
- Histamine, prostaglandins, leukotrienes, platelet activating factor (PAF) involved
- Cross sensitization to soy protein may also occur
- Diagnosis
- Typical acute inflamamtory IgE-mediated disease
- Clinical sypmtoms usually develop in seconds, but can occur after 2 hours of ingestion
- Allergy nearly always requires eating peanut; not usually triggered by skin or air contact
- Most occur with skin involvement; 50% respiratory, >30% gastrointestinal tract
- Two organ systems occur in >30% and 3 in >20% of intial reactions [5]
- Symptoms as below for other hypersensitivity reactions
- Evidence of peanut-specific circulating IgE required for definitive diagnosis
- Levels of peanut-specific IgE >14 kU/L diagnostic in symptomatic persons
- If levels are <14 kU/L, then food challenge may be used
- Treatment
- All peanut-allergic persons should have an emergency management plan
- Includes epinephrine (Epi-Pen®) and antihistamines on hand at all times
- Epinephrine IM: 0.01ml of 1:1000/kg q10-20 minutes; maximum 0.5mL
- Diphenhydramine oral or IM 1mg/kg up to 75mg maximum
- Epinephrine IV for severe hypotension if needed
- Oral prednisone 1-2mg/kg to maximum 75mg OR
- Methylprednisolone IV 2mg/kg to maximum 250mg
- Possible use of H2-receptor antagonists (300mg ranitidine for adults)
- Discharge on 3 days of prednisone (1mg/kg po to max 75mg) AND anti-H1 histamine
- Any peanut reaction should be evaluated and observed for up to 4 hours (late phase reseponse)
- Anti-IgE monoclonal antibody can reduce sensitivity to peanuts [4]
E. Symptoms and Signs
- Most due to activation of mast cells and occur within 4 hours of food ingestion
- Symptoms may progress with eventual full blown anaphylaxis
- Early: itchy, swollen lips, itchy mouth, swollen tongue, itchy throat, rhinorrhea, itchy eyes
- Progression: difficulty swallowing, abdominal cramps, diarrhea, hives, angioedema
- Severe: stridor, bronchospasm, nausea, vomiting, hypotension, death
- Rarely, if ever, causes isolated rhinitis or asthma (except some peanut allergies)
- Most children grow out of their food allergies
F. Evaluation
- Careful history about foods and amounts ingested is crucial
- Note that foods eaten >4 hours from reaction probably not implicated
- Physical examination directed at signs described above
- Total IgE levels and presence of eosinophilia are non-specific
- Skin Testing
- Subcutaneous skin test are gold standard for detection of food specific IgE
- Patient should be off of antihistamines for appropriate length of time
- Positive (histamine) and negative (saline-glycerine) control skin tests used
- Positive reaction defined as wheal diameter at least 3mm
- Intradermal reactions should not be used
- Oral challenges are only attempted when foods cannot be avoided easily
G. Food Additives
- Sulfites
- Bacterial inhibitors, anti-fermentors, preservatives, anti-browning for vegetables
- Vast majority of reactions are asthmatic in nature
- Sulfur dioxide may be released and cause bronchospasm
- Reactions can be confirmed with oral challenge in supervised setting only
- Treatment by avoidance
- Monosodium Glutamate (MSG)
- First reported cases involved "Chinese Restaurant Syndrome"
- Headache, occipital burning, chest tightness, nausea and sweating
- Usually 15-20 minutes after ingestion
- Asthmatics are more susceptible, with early or late reactions, may be severe
- Reactions can be confirmed with oral challenge in supervised setting only
- Food Dyes
- Two Types: Azo group (-N=N-) and non-Azo group
- Tartrazine and other azo dyes sometimes implicated in urticaria
- No association between non-Azo dyes and urticaria
H. Treatment
- Directed at symptoms
- High dose antihistamines useful for urticarial symptoms
- Asthma and/or bronchospasm is treated as usual
- Large fluid bolus and epinephrine may be required
- Vasopressor support may be necessary
- Treatment with anti-IgE monoclonal Ab can reduce peanut and other food allergies [4]
References
- Sicherer SH. 2002. Lancet. 360(9334):701
- Sampson HA. 2002. NEJM. 346(17):1294
- Lack G, Fox D, Northstone K, Golding J. 2003. NEJM. 348(11):977
- Leung DY, Sampson HA, Yunginger JW, et al. 2003. NEJM. 348(11):986
- Burks AW. 2008. Lancet. 371(9623):1538